Jefferies lifts Centene price target to $69, keeps Hold
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Jefferies raised its Centene (NYSE: CNC) price target to $69 from $59 while maintaining a Hold rating, citing the health insurer's handling of third-quarter headwinds and strong earnings power. The firm projects 2028 EPS of roughly $6.60, following Centene's Q3 2026 earnings beat and positive outlooks from Cantor Fitzgerald and BofA Securities.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.